Drug-coated balloons for the prevention of vascular restenosis.

  title={Drug-coated balloons for the prevention of vascular restenosis.},
  author={William A Gray and Juan F Granada},
  volume={121 24},
From early in the history of percutaneous cardiovascular intervention, restenosis has been one of the most important clinical and biological measures of success, and a great deal of effort has been put into understanding the mechanisms responsible.1,2 Restenosis is the result of the interaction of a variety of mechanical and biological processes that begin immediately after balloon injury, including early vessel recoil,3,4 negative vascular remodeling,5 and excessive neointimal proliferation.5… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 45 extracted citations


Publications referenced by this paper.
Showing 1-10 of 54 references

Biological effect on coronary restenosis of bare metal stents crimped on paclitaxel coated balloons: preliminary animal data in the porcine overstretch model

  • T Thim, K Milewski, +6 authors JF. Granada
  • Am J Cardiol. 2009;104:177-D. Abstract
  • 2009

Inhibition of coronary neointimal hyperplasia in swine using a novel zotarolimus-eluting balloon catheter

  • B Cremers, JL Toner, +7 authors B. Scheller
  • Eur Heart J. 2009;30:532
  • 2009

Pilot study of paclitaxel eluting balloon (Cotavance Technology) followed by bare metal stent implantation: effect on neointimal formation in the iliofemoral arterial territory of normal swine

  • K Milewski, A Tellez, +7 authors GL. Kaluza
  • Am J Cardiol. 2009;104:181-D. Abstract
  • 2009

Similar Papers

Loading similar papers…